Top-News
Biotechnologie USA

Dyadic International News

Aktie
WKN:  A0JK0A ISIN:  US26745T1016 US-Symbol:  DYAI
1,3712 €
+0,00 €
0,00%
1,52 $ 15.07.24
Handeln Depot/Watchlist
Aktienanzahl *
-
Marktkapitalisierung *
-
Streubesitz
53,90%
Index-Zugehörigkeit
-
IR-Website
zur Website

Dyadic International News

17.12.21 - GlobeNewswire
Dyadic Announces Research, License and Collaboration Agreement with Janssen for the Manufacture of Therapeutic Protein Candidates using its C1 Platform
JUPITER, Fla., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on ...
11.08.21 - PR Newswire
Thinking about buying stock in Dyadic Int, Seanergy Maritime, Cleveland-Cliffs, United States Steel, or Lightning Emotors?
Thinking about buying stock in Dyadic Int, Seanergy Maritime, Cleveland-​Cliffs, United States Steel, or Lightning Emotors? PR Newswire
27.07.21 - PR Newswire
Thinking about buying stock in Tyme Technologies, New Oriental Education, Dyadic International, KE Holdings, or Iterum Therapeutics?
Thinking about buying stock in Tyme Technologies, New Oriental Education, Dyadic International, KE Holdings, or Iterum Therapeutics? PR Newswire
26.04.21 - GlobeNewswire
Dyadic International veranstaltet Kamingespräch mit dem Titel „The Potential of the Transformative Dyadic C1 Protein Technology in Helping Meet Global Health Challenges“
Das Kamingespräch findet am Dienstag, den 4. Mai 2021, um 16 Uhr CEST statt
22.04.21 - GlobeNewswire
Dyadic International Hosting a Fireside Chat on “The Potential of the Transformative Dyadic C1 Protein Technology in Helping Meet Global Health Challenges”
Fireside Chat Being Held on Tuesday, May 4th @ 10am Eastern Time
24.03.21 - GlobeNewswire
Dyadic und Medytox entwickeln Impfstoffe gegen COVID-19-Varianten
Ausweitung der seit Juli 2020 bestehenden Zusammenarbeit im Bereich der COVID-19-Impfstoffforschung Medytox und Dyadic entwickeln gemeinsam COVID-19-Impfstoffe ...
23.03.21 - GlobeNewswire
Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants
Expanding existing COVID-19 vaccine research collaboration which began in July 2020. Medytox and Dyadic to co-​develop C1 enabled COVID-19 vaccines and/or boosters which will ...
22.03.21 - PR Newswire
Thinking about buying stock in Support.com, Seneca Biopharma, Hall of Fame Resort & Entertainment, Dyadic International, or Stonemor?
Thinking about buying stock in Support.com, Seneca Biopharma, Hall of Fame Resort & Entertainment, Dyadic International, or Stonemor? PR Newswire
17.09.20 - DGAP
Dyadic International, Inc.: Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development
DGAP-News: Dyadic International, Inc. / Key word(s): Miscellaneous Dyadic International, Inc.: Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug ...
30.03.20 - DGAP
Dyadic Announces Nonexclusive Research License with WuXi Biologics
DGAP-News: Dyadic International, Inc. / Key word(s): Miscellaneous Dyadic Announces Nonexclusive Research License with WuXi Biologics 30.03.2020 / 15:03 The issuer is solely ...
08.05.19 - DGAP
Dyadic and Serum Institute of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products and Vaccines
DGAP-News: Dyadic International, Inc. / Key word(s): Miscellaneous Dyadic and Serum Institute of India to Develop and Manufacture Globally Affordable and Accessible Antibody ...
08.04.19 - PR Newswire
OTC Company Investor Presentations Now Available for On-Demand Viewing
OTC Company Investor Presentations Now Available for On-Demand Viewing Individual and institutional investors as well as advisors are invited to log-on to ...
01.04.19 - PR Newswire
Dyadic International to Webcast, Live, at VirtualInvestorConferences.com April 4th
Dyadic International to Webcast, Live, at VirtualInvestorConferences.com April 4th Company invites individual and institutional investors, as well as advisors and analysts, to attend ...
28.03.19 - PR Newswire
Live Investor Conference & Webinar April 4th
Live Investor Conference & Webinar April 4th Company executives share vision, answer questions live at VirtualInvestorConferences.com PR Newswire
13.03.19 - PR Newswire
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference OTCQX and OTCQB Companies Featured at 2019 ROTH Conference PR Newswire
06.03.18 - PR Newswire
VIDEO: Dyadic International Inc., President, Chief Executive Officer and Director Mark A. Emalfarb and Chief Commercial Officer Matthew Jones Featured in OTCQX Video Series
VIDEO: Dyadic International Inc., President, Chief Executive Officer and Director Mark A. Emalfarb and Chief Commercial Officer Matthew Jones Featured in OTCQX Video Series PR ...
09.10.17 - PR Newswire
Dyadic International Presentation Now Available for On-Demand Viewing
Dyadic International Presentation Now Available for On-Demand Viewing PR Newswire
28.09.17 - PR Newswire
Dyadic International to Webcast, Live, at VirtualInvestorConferences.com October 5
Dyadic International to Webcast, Live, at VirtualInvestorConferences.com October 5 PR Newswire
25.09.17 - PR Newswire
OTC Markets Group Announces Agenda for OTCQX Virtual Investor Conference on October 5
OTC Markets Group Announces Agenda for OTCQX Virtual Investor Conference on October 5 PR Newswire
16.11.16 - PR Newswire
StockNewsNow.com Publishes New SNNLive Video Interviews with Dyadic International, Inc. Team Discussing Dyadic's C1 Technology Platform and the Biologics Industry
StockNewsNow.com Publishes New SNNLive Video Interviews with Dyadic International, Inc. Team Discussing Dyadic's C1 Technology Platform and the Biologics Industry PR ...

Newssuche

Videos

newspaper
04.09.24 -9,76%
Technical Trading: Zucker Long kurzfristig
Sugar Long Typ: Turbo Open End WKN: VV50DP Hebel: 5,06 Laufzeit: OpenEnd Einstieg: Market ... Mehr »